REFERENCES:
1. Journal of the Indian Institute of Science VOL 92:2 Apr.–Jun. 2012
2. Frank Alexis, Eric M. Pridgen, Robert Langer, and Omid C. Farokhzad/ Nanoparticle Technologies for Cancer Therapy,2015
3. Hanan, D., Weinberg, R. A. “Hallmarks of cancer: The next generation”, Cell, 2011 Mar 4;144(5):646-74
4. https://en.wikipedia.org/wiki/Cancer
5. https://en.wikipedia.org/wiki/Management_of_cancer
6. Adler HI, Fisher WD, Cohen A, Hardigree AA (1967) Miniature Escherichia coli cells deficient in DNA. Proc Natl Acad Sci USA 57:321–326
7. James JS (1995a) DOXIL approved by FDA. AIDS Patient Care 9:306
8. Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N (2004) Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 91:1775–1781
9. Overall CM, Kleifeld O (2006) Tumour microenvironment - opinion: validating matrix metalloproteinasesas drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227–239
10. Salvador-Morales C, Gao W, Ghatalia P, Murshed F, Aizu W, Langer R, Farokhzad OC (2009a) Multifunctional nanoparticles for prostate cancer therapy. Expert Rev Anticancer Ther9:211–221
11. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, L. Gianni, Anthracyclines: Molecular advances and pharmacological developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 2004, 56, 185–229.
12. A.C. de Verdie`re, C. Dubernet, F. Ne´mati, E. Soma, M. Appel, J. Ferte´, S. Bernard, F. Puisieux, P. Couvreur, Reversion of multidrug resistance with polyalkylcyanoacrylatenanoparticles: Towards a mechanism of action, Br. J. Cancer 1997, 76, 198– 205
13. T. Ameller, V. Marsaud, P. Legrand, R. Gref, J.M. Renoir, In vitro and in vivo biologic evaluation of long-circulating biodegradable drugcarriers loaded with the pureantiestrogen RU 58668, Int. J. Cancer2003, 106, 446–454.
14. S. Maillard, T. Ameller, J. Gauduchon, A. Gougelet, F. Gouilleux, P. Legrand, V. Marsaud, E. Fattal, B. Sola, J.M. Renoir,Innovative drug delivery nanosystemsimprove the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma, J. Steroid Biochem. Mol. Biol. 2005, 94, 111–121.
15. D. Bhadra, S. Bhadra, S. Jain, N.K. Jain, A PEGylated dendritic nanoparticulate carrier of fluorouracil, Int. J. Pharm. 2003, 257, 111–124.
16. C.L. Lo, K.M. Lin, G.H. Hsiue, Preparation and characterization of intelligent core-shell nanoparticles based on poly(D,L-lactide)-g-poly(Nisopropyl acrylamide-co-methacrylicacid), J. Control. Release 2005, 104, 477–488.
17. H. Miura, H. Onishi, M. Sasatsu, Y. Machida, Antitumor characteristics of methoxypolyethylene glycol-poly(DLlactic acid) nanoparticles containing camptothecin, J. Control. Release 2004, 97, 101–113
18. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A.G. Karydas, D.S. Ithakissios, PLGAmPEGnanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties, J. Control. Release 2002, 79, 123–135.
19. A.K. Singla, A. Garg, D. Aggarwal,Paclitaxel and its formulations, Int.J. Pharm. 2002, 235, 179–192.
20. J. Zhou, F.Q. Zeng, C. Li, Q.S. Tong, X. Gao, S.S. Xie, L.Z. Yu, Preparation of arsenic trioxide-loaded albuminutesimmuno-nanospheresand its specific killing effect on bladder cancer cell in vitro, Chin. Med. J. 2005, 118, 50–55.
21. B. Salomone, R. Ponti, M.R. Gasco, E. Ugazio, P. Quaglino, S. Osella- Abate, M.G. Bernengo, In vitro effects of cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction, Clin. Exp. Metastasis 2001, 18, 663–673.
22. P. Beck, J. Kreuter, R. Reszka, I. Fichtner, Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drugmitoxantrone in murine tumourmodels, J. Microencapsul. 1993, 10, 101–114.
23. S Jain, D G Hirst and J M O’Sullivan, Gold nanoparticles as novel agents for cancer therapy, The British Journal of Radiology, 85 (2012), 101–113.